Clinical Trials on Bone Sarcoma

Total 28363 results

Memorial Sloan Kettering Cancer Center
Incyte Corporation

Active, not recruiting

Retifanlimab (Anti-PD-1 Antibody) With Gemcitabine and Docetaxel in Patients With Advanced Soft Tissue Sarcoma

Sarcoma | Soft Tissue Sarcoma | Soft Tissue Sarcoma Adult | Sarcoma,Soft Tissue

United States
Second Affiliated Hospital, School of Medicine,...
Peking University People's Hospital; Qilu Hospital of Shandong University; Ruijin... and other collaborators

Not yet recruiting

A Study of Sulfatinib on Relapsed or Refractory Drug Resistant Osteosarcoma

Osteosarcoma

China, Korea, Republic of
Power Life Sciences Inc.

Not yet recruiting

Assessing Clinical Trial Experiences of Patients With Osteosarcoma

Osteosarcoma
University College, London
Bone Cancer Research Trust

Recruiting

ICONIC: Improving Outcomes Through Collaboration in OsteosarComa (ICONIC)

Osteosarcoma

United Kingdom
Peking University People's Hospital

Not yet recruiting

Patient-derived Xenograft (PDX) Modeling to Test Drug Response for High-grade Osteosarcoma

Osteosarcoma
Sun Yat-sen University
Guangdong Provincial Hospital of Traditional Chinese Medicine; Qilu Hospital... and other collaborators

Recruiting

Clinical Trial of Lithium Carbonate Combined With Neo-adjuvant Chemotherapy to Treat Osteosarcoma (Li2CO3)

Osteosarcoma

China
Italian Sarcoma Group

Completed

ABCB1/P-glycoprotein Expression as Biologic Stratification Factor for Patients With Non Metastatic Osteosarcoma (ISG/OS-2)

Osteosarcoma

Italy
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Collecting and Storing Samples of Blood and Tumor Tissue From Patients With Osteosarcoma

Osteosarcoma

United States, Canada, Australia, New Zealand, Puerto Rico
Peking University People's Hospital
Jiangsu HengRui Medicine Co., Ltd.; OrigiMed

Completed

Cancer Genome Study Using Samples From Patients Treated on Clinical Trial SHR1020-SHR-1210-II-OS (CSSG-02)

Osteosarcoma

China
Istituto Ortopedico Rizzoli

Completed

The Prognostic Value of Serum Biomarkers in Osteosarcoma

Osteosarcoma

Italy
Duke University

Completed

Monocyte Phenotypic and Functional Differences

Osteosarcoma

United States
Millennium Pharmaceuticals, Inc.

Terminated

Surveillance Study of Patients With Newly Diagnosed Osteosarcoma

Osteosarcoma

Austria
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Genetic Biomarkers in Tissue Samples From Patients With Osteosarcoma

Osteosarcoma

United States
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Studying DNA in Tumor Tissue Samples From Patients With Localized or Metastatic Osteosarcoma

Sarcoma
Broto, Javier Martín, M.D.

Completed

Trial With Gemcitabine and Rapamycin in Second Line of Metastatic Osteosarcoma (GEIS-29)

Osteosarcoma
BTG International Inc.
M.D. Anderson Cancer Center

Terminated

High Dose Methotrexate With Leucovorin Rescue With or Without Glucarpidase in Osteosarcoma

Osteosarcoma
M.D. Anderson Cancer Center

Terminated

Doxorubicin With Cisplatin, High-Dose Methotrexate, and Additional Risk-Adapted Outpatient Chemotherapy

Osteosarcoma

United States
Millennium Pharmaceuticals, Inc.

Completed

Mifamurtide (L-MTP-PE) for High-Risk Osteosarcoma

Osteosarcoma

United States
European Organisation for Research and Treatment...
Medical Research Council

Completed

Combination Chemotherapy and Surgery With or Without G-CSF in Treating Patients With Osteosarcoma

Sarcoma

France, Saudi Arabia, Denmark, Belgium, Netherlands, Portugal, Slovenia, United Kingdom
Eli Lilly and Company

Completed

Chemotherapy for Patients With Osteosarcoma

Osteosarcoma

Germany, Spain, France, Italy, United Kingdom
St. Jude Children's Research Hospital
National Institutes of Health (NIH); Immunex/Berlex

Completed

Osteosarcoma1999-A Study Of Intensive Chemotherapy for Osteosarcoma

Osteosarcoma

United States, Chile
Mayo Clinic
National Cancer Institute (NCI)

Completed

Combination Chemotherapy in Treating Patients Undergoing Surgery for Newly Diagnosed High-Grade Osteosarcoma

Sarcoma
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Completed

Dalteparin in Preventing DVT in Participants With Cancer

Soft Tissue Sarcoma | Lymphoma | Plasma Cell Myeloma | Bone Sarcoma | Femur Fracture | Metastatic Neoplasm | Pathologic Fracture

United States
National Cancer Institute (NCI)

Active, not recruiting

Talimogene Laherparepvec and Radiation Therapy in Treating Patients With Newly Diagnosed Soft Tissue Sarcoma That Can Be Removed by Surgery

Soft Tissue Sarcoma | Leiomyosarcoma | Liposarcoma | Undifferentiated Pleomorphic Sarcoma | Soft Tissue Sarcoma of the Trunk and Extremities | Stage I Soft Tissue Sarcoma AJCC v7 | Stage II Soft Tissue Sarcoma AJCC v7 | Sarcoma G2 | Sarcoma G3

United States, Canada
National Cancer Institute (NCI)

Terminated

BMS-247550 in Treating Patients With Advanced Soft Tissue Sarcoma

Recurrent Adult Soft Tissue Sarcoma | Stage III Adult Soft Tissue Sarcoma | Stage IV Adult Soft Tissue Sarcoma

United States
National Cancer Institute (NCI)

Active, not recruiting

Testing Atezolizumab Alone or Atezolizumab Plus Bevacizumab in People With Advanced Alveolar Soft Part Sarcoma

Metastatic Alveolar Soft Part Sarcoma | Unresectable Alveolar Soft Part Sarcoma

United States
University of Washington
National Cancer Institute (NCI)

Completed

Pazopanib Hydrochloride Followed by Chemotherapy and Surgery in Treating Patients With Soft Tissue Sarcoma

Stage III Adult Soft Tissue Sarcoma | Stage IV Adult Soft Tissue Sarcoma | Stage IIA Adult Soft Tissue Sarcoma

United States
Centre Leon Berard

Recruiting

Multiparametric Quantitative MRI and Response to Neoadjuvant Radiotherapy for Soft-tissue Sarcoma (SarQuantIRM)

Soft Tissue Sarcoma | Resectable Soft Tissue Sarcoma | Adult Soft Tissue Sarcoma

France
Foghorn Therapeutics Inc.

Terminated

FHD-609 in Subjects With Advanced Synovial Sarcoma or Advanced SMARCB1-Loss Tumors

Advanced Synovial Sarcoma

United States, Spain, France, Italy
Institute of Cancer Research, United Kingdom
Royal Marsden NHS Foundation Trust

Unknown

A Trial of Cediranib in the Treatment of Patients With Alveolar Soft Part Sarcoma (CASPS) (CASPS)

Alveolar Soft-part Sarcoma

Australia, United Kingdom, Spain
Radiation Therapy Oncology Group
National Cancer Institute (NCI)

Withdrawn

Combination Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Primary or Recurrent Sarcoma

Recurrent Adult Soft Tissue Sarcoma | Stage III Adult Soft Tissue Sarcoma | Stage IVA Adult Soft Tissue Sarcoma | Stage IIB Adult Soft Tissue Sarcoma | Stage IIC Adult Soft Tissue Sarcoma

United States, Canada
National Cancer Institute (NCI)

Completed

Cixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue Sarcoma

Recurrent Childhood Rhabdomyosarcoma | Recurrent Adult Soft Tissue Sarcoma | Stage III Adult Soft Tissue Sarcoma | Stage IV Adult Soft Tissue Sarcoma | Dermatofibrosarcoma Protuberans | Previously Treated Childhood Rhabdomyosarcoma | Recurrent Childhood Soft Tissue Sarcoma | Adult Rhabdomyosarcoma | Adult Angiosarcoma and other conditions

United States
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)

Withdrawn

NY-ESO-1 Specific T Cells After Cyclophosphamide in Treating Patients With Advanced Synovial Sarcoma or Myxoid/Round Cell Liposarcoma

Myxoid/Round Cell Liposarcoma | Recurrent Adult Soft Tissue Sarcoma | Stage III Adult Soft Tissue Sarcoma | Stage IV Adult Soft Tissue Sarcoma | Adult Synovial Sarcoma

United States
National Cancer Institute (NCI)
Radiation Therapy Oncology Group

Terminated

Preoperative Thalidomide With Radiation Therapy For Patients With Low-Grade Primary Soft Tissue Sarcoma or Thalidomide With Radiation Therapy and Chemotherapy For Patients With High-Grade or Intermediate-Grade Primary Soft Tissue Sarcoma of the Arm, Leg, or Body Wall

Recurrent Adult Soft Tissue Sarcoma | Stage I Adult Soft Tissue Sarcoma AJCC v7 | Stage II Adult Soft Tissue Sarcoma AJCC v7 | Stage III Adult Soft Tissue Sarcoma AJCC v7

United States
Institut Bergonié

Recruiting

Prospective Identification of Predictive Biomarkers of Trabectedin Efficacy in Non-L Soft-tissue Sarcoma Patients (PIPER)

Soft Tissue Sarcoma Adult | Solitary Fibrous Tumors | Hemangioendothelioma | Synovial Sarcoma | Undifferentiated Pleomorphic Sarcoma | Epithelioid Sarcoma | Desmoplastic Round Cell Tumor

France
Dana-Farber Cancer Institute
Merck Sharp & Dohme LLC

Suspended

Pembrolizumab in Neoplasms or Lymphomas

Lymphoma | Histiocytic Sarcoma | Follicular Dendritic Cell Sarcoma | Interdigitating Dendritic Cell Sarcoma

United States
Montefiore Medical Center

Recruiting

Upfront Surgical Resection for Osteosarcoma (UFSR for OS)

Osteosarcoma

United States
Assiut University

Recruiting

Donor Site Morbidity After Free Vascularized Fibular Graft

Osteosarcoma

Egypt
The First Affiliated Hospital of Xinxiang Medical...

Not yet recruiting

Trilaciclib Combined With Chemotherapy for Perioperative Treatment of Osteosarcoma

Osteosarcoma

China
Wuhan Union Hospital, China

Not yet recruiting

Tucidinostat Plus Apatinib for Advanced Osteosarcoma

Osteosarcoma
Jonsson Comprehensive Cancer Center

Recruiting

An Organoid-based Functional Precision Medicine Trial in Osteosarcoma (PREMOST)

Osteosarcoma

United States
Second Affiliated Hospital, School of Medicine,...

Recruiting

A Clinical Study of Surufatinib Combined With Chemotherapy as Neoadjuvant Treatment in Osteosarcoma

Osteosarcoma

China
Hansoh BioMedical R&D Company

Recruiting

ARTEMIS-002: HS-20093 in Patients With Relapsed or Refractory Osteosarcoma and Other Sarcomas

Sarcoma | Osteosarcoma

China
West China Hospital

Recruiting

Predictive Models of Treatment Responses and Survival Outcomes in Patients With Osteosarcoma

Osteosarcoma

China
Cairo University

Not yet recruiting

Efficacy of Exercise Program on Osteosarcoma Patients

Osteosarcoma
Second Affiliated Hospital, School of Medicine,...

Not yet recruiting

Phase II Clinical Trial Scheme of Ganoderma Lucidum Spore Powder for Postoperative Chemotherapy of Osteosarcoma

Osteosarcoma
Second Affiliated Hospital, School of Medicine,...
Leiden University Medical Center

Not yet recruiting

A Phase I Clinical Trial of Neoadjuvant Chemotherapy With/Without SPIONs/SMF for Patients With Osteosarcoma

Osteosarcoma
Sun Yat-sen University
Jiangsu HengRui Medicine Co., Ltd.

Recruiting

Study of Camrelizumab in Combination With Neoadjuvant Chemotherapy in the Treatment of Osteosarcoma

Osteosarcoma

China
OHSU Knight Cancer Institute
Oregon Health and Science University; BTG International Inc.

Recruiting

Glucarpidase After High-Dose Methotrexate in Patients With Osteosarcoma

Osteosarcoma

United States
University of Colorado, Denver

Recruiting

Losartan + Sunitinib in Treatment of Osteosarcoma

Osteosarcoma

United States

Clinical Trials on Bone Sarcoma

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Jamaica

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations